Search for: "TEVA PHARMACEUTICALS USA, INC." Results 281 - 300 of 482
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun… [read post]
14 Mar 2014, 8:00 am by John Elwood
  First up is Teva Pharmaceuticals USA, Inc. v. [read post]
11 Mar 2014, 9:09 pm by Ben Vernia
Teva Pharmaceuticals USA is located in North Wales, Pa., and IVAX LLC is a Florida company [read post]
13 Feb 2014, 8:36 am by m zamora
– topical gel applied to the skinAxiron (Lilly USA, LLC) – topical cream applied to underarmBio-T-Gel (Teva Pharmaceuticals) – topical gel applied to skinDelatestryl (Endo Pharmaceuticals) – injection or solutionDepo-Testosterone (Unigen Life Sciences) – injection solutionFortesta (Endo Pharmaceuticals) – topical gel applied to skinStriant (Auxilium Pharmaceuticals) – buccal… [read post]
10 Feb 2014, 7:01 pm by H. Scott Leviant
Teva Pharmaceuticals USA, Inc. was described as the end of the world by business interests when the Ninth Circuit held that attorneys could avoid CAFA removal by filing separate cases with fewer than 100 plaintiffs in each case to avoid the mass action provision in CAFA. [read post]
6 Feb 2014, 9:59 pm by Patent Docs
By Andrew Williams -- The standard of review at the Federal Circuit is important. [read post]
18 Aug 2013, 8:54 pm by Patent Docs
Teva Biopharmaceuticals USA, Inc. et al. 2:13-cv-04911; filed August 12, 2013 in the District Court of New Jersey • Plaintiffs: Amgen Inc.; Amgen Manufacturing, Limited • Defendants: Teva Biopharmaceuticals USA, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]